Microsoft doubles down on AI in health
Microsoft is no stranger to the AI biotech space, with a handful of granted patents spanning neurological, ophthalmic, and musculoskeletal medicines. Now the company wants to dive deeper.
This week, Microsoft announced a $40 million AI initiative aimed at research on global health challenges called AI for Health. The program will equip academia and non-profit research groups in their efforts to develop diagnostics, treatments, and preventative measures, specifically in health for under-served populations.
Previously, Microsoft entered a partnership with Swiss pharmaceutical company Novartis to equip all of their associates with AI tools. Now, the Novartis foundation, along with the Fred Hutchinson Cancer Research Center, Seattle Children’s Research Institute, PATH, Intelligent Retinal Imaging Systems and the international development organization BRAC are among the first grantees of AI for Health.
Related Posts
Cala Health Claims to Have the only Patented Neurostimulation for Essential Tremor Treatment. The Patent Data Disagrees
Cala Health has figured out that innovations backed by patents make them exponentially more valuable in the marketplace. However, in a zest…
Capital One is Investing in AI Biotech? What’s in their wallet?
In the past 18 months, Capital One has expanded past its usual banking activities, and begun exploring the AI Biotech Sector. But do they…
Google AI Reinvents Speech Recognition. Who will follow?
There is no doubt that the big 5 tech companies (Apple, Amazon, Google, Facebook, and Microsoft) have developed massive IP portfolios in…